Resilience Therapeutics Overview
- Year Founded
-
2015
- Status
-
Out of Business
- Employees
-
8
- Latest Deal Type
-
Out of Business
Resilience Therapeutics General Information
Description
Operator of a drug discovery company intended to focus on developing small molecule therapeutics for psychiatric conditions including PTSD and Social Anxiety Disorder. The company is focused on developing therapeutics that provide both symptom relief and potential disease modification for PTSD and other Stress-Related Disorders, providing medical practitioners with first-in-class therapeutics that provide both symptom relief and potential disease modification for anxiety and trauma-related disorders.
Contact Information
Website
www.resiliencetx.comCorporate Office
- Boston, MA
- United States
Corporate Office
- Boston, MA
- United States
Resilience Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 31-Dec-2021 | Completed | Out of Business | |||
| 2. Seed Round | 03-Mar-2016 | Completed | Generating Revenue | |||
| 1. Seed Round | 30-Jul-2015 | $2.92M | $2.92M | Completed | Generating Revenue |
Resilience Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Resilience Therapeutics Comparisons
Industry
Financing
Details
Resilience Therapeutics Competitors (43)
One of Resilience Therapeutics’s 43 competitors is Neurelis, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neurelis | Venture Capital-Backed | San Diego, CA | ||||
| Tonix Pharmaceuticals Holding | Corporation | Chatham, NJ | ||||
| NeuroNascent | Venture Capital-Backed | Clarksville, MD | ||||
| Neurogene | Formerly VC-backed | New York, NY | ||||
| LeonaBio | Formerly VC-backed | Bothell, WA |
Resilience Therapeutics Signals
Resilience Therapeutics FAQs
-
When was Resilience Therapeutics founded?
Resilience Therapeutics was founded in 2015.
-
Where is Resilience Therapeutics headquartered?
Resilience Therapeutics is headquartered in Boston, MA.
-
What is the size of Resilience Therapeutics?
Resilience Therapeutics has 8 total employees.
-
What industry is Resilience Therapeutics in?
Resilience Therapeutics’s primary industry is Drug Discovery.
-
Is Resilience Therapeutics a private or public company?
Resilience Therapeutics is a Private company.
-
What is Resilience Therapeutics’s current revenue?
The current revenue for Resilience Therapeutics is .
-
How much funding has Resilience Therapeutics raised over time?
Resilience Therapeutics has raised $3.42M.
-
Who are Resilience Therapeutics’s competitors?
Neurelis, Tonix Pharmaceuticals Holding, NeuroNascent, Neurogene, and LeonaBio are some of the 43 competitors of Resilience Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process